MY172337A - Vortioxetine manufacturing process - Google Patents

Vortioxetine manufacturing process

Info

Publication number
MY172337A
MY172337A MYPI2015002072A MYPI2015002072A MY172337A MY 172337 A MY172337 A MY 172337A MY PI2015002072 A MYPI2015002072 A MY PI2015002072A MY PI2015002072 A MYPI2015002072 A MY PI2015002072A MY 172337 A MY172337 A MY 172337A
Authority
MY
Malaysia
Prior art keywords
vortioxetine
manufacturing process
dimethylthiophenol
complexation
ate
Prior art date
Application number
MYPI2015002072A
Other languages
English (en)
Inventor
Thomas Ruhland
Kim Lasse Christensen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of MY172337A publication Critical patent/MY172337A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
MYPI2015002072A 2013-02-22 2014-02-20 Vortioxetine manufacturing process MY172337A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361767883P 2013-02-22 2013-02-22
DKPA201300104 2013-02-22

Publications (1)

Publication Number Publication Date
MY172337A true MY172337A (en) 2019-11-21

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015002072A MY172337A (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Country Status (37)

Country Link
US (1) US9353073B2 (cg-RX-API-DMAC7.html)
EP (1) EP2958903B1 (cg-RX-API-DMAC7.html)
JP (1) JP6464098B2 (cg-RX-API-DMAC7.html)
KR (1) KR102230628B1 (cg-RX-API-DMAC7.html)
CN (1) CN104995181B (cg-RX-API-DMAC7.html)
AP (1) AP2015008640A0 (cg-RX-API-DMAC7.html)
AU (1) AU2014220735B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015019268B1 (cg-RX-API-DMAC7.html)
CA (1) CA2901821A1 (cg-RX-API-DMAC7.html)
CL (1) CL2015002309A1 (cg-RX-API-DMAC7.html)
CR (1) CR20150423A (cg-RX-API-DMAC7.html)
CY (1) CY1118883T1 (cg-RX-API-DMAC7.html)
DK (1) DK2958903T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2015000187A (cg-RX-API-DMAC7.html)
EA (1) EA027756B1 (cg-RX-API-DMAC7.html)
ES (1) ES2625380T3 (cg-RX-API-DMAC7.html)
GE (1) GEP201706749B (cg-RX-API-DMAC7.html)
HR (1) HRP20170607T1 (cg-RX-API-DMAC7.html)
IL (1) IL240501B (cg-RX-API-DMAC7.html)
LT (1) LT2958903T (cg-RX-API-DMAC7.html)
MA (1) MA38338B1 (cg-RX-API-DMAC7.html)
ME (1) ME02671B (cg-RX-API-DMAC7.html)
MX (1) MX362355B (cg-RX-API-DMAC7.html)
MY (1) MY172337A (cg-RX-API-DMAC7.html)
PE (1) PE20151589A1 (cg-RX-API-DMAC7.html)
PH (1) PH12015501807B1 (cg-RX-API-DMAC7.html)
PL (1) PL2958903T3 (cg-RX-API-DMAC7.html)
PT (1) PT2958903T (cg-RX-API-DMAC7.html)
RS (1) RS55932B1 (cg-RX-API-DMAC7.html)
RU (1) RU2652265C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201506651SA (cg-RX-API-DMAC7.html)
SI (1) SI2958903T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201700238T1 (cg-RX-API-DMAC7.html)
TN (1) TN2015000335A1 (cg-RX-API-DMAC7.html)
UA (1) UA116236C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014128207A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201506050B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2592694C2 (ru) 2010-08-18 2016-07-27 СЭМЬЮМЕД, ЭлЭлСи Дикетоны и гидроксикетоны в качестве активатора сигнального пути катенина
BR112015020391B1 (pt) 2013-02-22 2022-07-26 Samumed, Llc Gama-dicetonas como ativadoras da via de sinalização de wnt/beta-catenina
DK3206686T3 (da) 2014-08-20 2019-12-16 Samumed Llc Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
EP3274330A1 (en) 2015-03-26 2018-01-31 Cipla Limited Method for making serotonin reuptake inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
CN108473451B (zh) * 2016-02-08 2022-07-15 H.隆德贝克有限公司 1-[2-(2,4-二甲基-苯基硫烷基)-苯基]哌嗪的合成
MX2018015759A (es) 2016-07-01 2019-03-21 H Lundbeck As Regimenes de dosificacion de vortioxetina para el rapido inicio del efecto antidepresivo.
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
JP2005513128A (ja) * 2001-12-20 2005-05-12 ハー・ルンドベック・アクチエゼルスカベット アリールオキシフェニル及びアリールスルファニルフェニル誘導体
MY150647A (en) * 2006-06-16 2014-02-14 Lundbeck & Co As H 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
CN104995181B (zh) 2017-03-08
AU2014220735B2 (en) 2017-06-22
WO2014128207A1 (en) 2014-08-28
MA38338B1 (fr) 2018-10-31
EA027756B1 (ru) 2017-08-31
UA116236C2 (uk) 2018-02-26
SMT201700238T1 (it) 2017-07-18
LT2958903T (lt) 2017-08-25
IL240501A0 (en) 2015-09-24
TN2015000335A1 (en) 2017-01-03
DOP2015000187A (es) 2015-11-30
CL2015002309A1 (es) 2016-03-04
ME02671B (me) 2017-06-20
ZA201506050B (en) 2017-08-30
KR20150118146A (ko) 2015-10-21
SI2958903T1 (sl) 2017-09-29
BR112015019268A2 (pt) 2020-01-28
MX362355B (es) 2019-01-14
RS55932B1 (sr) 2017-09-29
EP2958903B1 (en) 2017-04-12
US9353073B2 (en) 2016-05-31
RU2015134407A (ru) 2017-03-28
HK1216098A1 (en) 2016-10-14
PE20151589A1 (es) 2015-12-03
MX2015010656A (es) 2015-12-17
GEP201706749B (en) 2017-10-10
DK2958903T3 (en) 2017-05-15
PL2958903T3 (pl) 2017-08-31
EA201591349A1 (ru) 2015-12-30
AP2015008640A0 (en) 2015-08-31
PT2958903T (pt) 2017-05-26
RU2652265C2 (ru) 2018-04-27
HRP20170607T1 (hr) 2017-06-30
AU2014220735A1 (en) 2015-08-20
JP2016509042A (ja) 2016-03-24
CR20150423A (es) 2015-10-20
CA2901821A1 (en) 2014-08-28
MA38338A1 (fr) 2016-09-30
PH12015501807A1 (en) 2015-11-09
US20160009670A1 (en) 2016-01-14
SG11201506651SA (en) 2015-09-29
ES2625380T3 (es) 2017-07-19
CN104995181A (zh) 2015-10-21
KR102230628B1 (ko) 2021-03-22
IL240501B (en) 2018-08-30
BR112015019268B1 (pt) 2023-01-10
PH12015501807B1 (en) 2019-05-31
EP2958903A1 (en) 2015-12-30
CY1118883T1 (el) 2018-01-10
JP6464098B2 (ja) 2019-02-06

Similar Documents

Publication Publication Date Title
PH12015501807B1 (en) Vortioxetine manufacturing process
UA113643C2 (xx) N-цикліламіди як нематоциди
MY182082A (en) Biheteroaryl compounds and uses thereof
IN2012DE00621A (cg-RX-API-DMAC7.html)
IN2012DE00620A (cg-RX-API-DMAC7.html)
NZ711192A (en) Process for making benzoxazepin compounds
IN2014DN09053A (cg-RX-API-DMAC7.html)
PH12015502665A1 (en) Improvements in or relating to organic compounds
MX2016001641A (es) Ciclobutilcarboxamidas como nematicidas.
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
AU2014371081A1 (en) Polyoxalates and a Process for the Production Thereof
MX2016005223A (es) Tinturas dispersas, su preparacion y su uso.
MX2015016766A (es) Nuevos derivados de tetrazolona.
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
MX2016000487A (es) Piridina-2-carboxamidas como nematicidas.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX2016005219A (es) Tinturas acidas, proceso para su produccion y su uso.
IN2014DE01203A (cg-RX-API-DMAC7.html)
MX2016005220A (es) Tinturas acidas, proceso para su produccion y su uso.
MX2016005222A (es) Tinturas acidas, proceso para su produccion y su uso.
ECSP15036884A (es) Proceso de fabricación de vortioxetina
MX2015017747A (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
UA87254U (ru) Соединение 1,1-диэтилкарбокси-2-метокси-2-трифторметилэтилен с потенциальными физиологическими свойствами
UA89447U (ru) Соединение 1,1-диэтилкарбокси-2-хлор-2-трифторметилэтилен с потенциальными физиологическими свойствами
UA87694U (uk) Сполука 4,5,6,7-тетрагідро-3н-2-n-(пара-метоксифенациламіно)-азепіну гідрохлорид з потенційними фізіологічними властивостями